CyberX Sponsors SANS Webinar with CISO of Teva Pharmaceuticals About Presenting OT Risk to the Board of Directors

Educational webinar will describe effective strategies for communicating with the board in business terms, focusing on supporting strategic business initiatives while ensuring readiness to deal with growing OT threats

BOSTON, April 24, 2019 (GLOBE NEWSWIRE) -- CyberX, the IIoT and industrial control system (ICS) security company, is sponsoring an educational SANS webinar featuring Ilan Abadi, CISO at Teva Pharmaceuticals and Daniel Shugrue, senior director of Industrial Cybersecurity at CyberX.

Titled “A CISO’s Perspective on Presenting OT Risk to the Board,” this educational webinar will provide attendees with strategies for effectively presenting OT risk to the board of directors in business terms. These include the need to describe how the security organization is enabling strategic business initiatives — such as IIoT and digitization — while ensuring organizational readiness to deal with growing OT threats, such as targeted attacks and destructive ransomware.

The webinar will also address how to explain the differences between IT and OT risk to the board, and how OT risk translates into business risk. Examples of OT risk include costly production downtime, safety and environmental incidents, and theft of sensitive intellectual property.

With over 19 years of experience, Abadi has deep knowledge of managing cyber incident response in regulated OT environments. In the webinar, Abadi will cover several key questions when addressing the board of directors, including when is cybersecurity not an IT issue, what are the legal implications of OT risk, what is an adequate risk management framework and budget, and what are the right metrics.

Shugrue will also briefly discuss how a modern OT cybersecurity platform can provide a spectrum of mitigation and protection controls for reducing key risks to a company’s “crown jewel” processes, including continuous risk and vulnerability management, threat monitoring, threat intelligence, and blocking.

The webcast will be held on Wednesday, May 1st, 2019 at 10:30 AM EDT. Those interested in attending can register here.

About Ilan Abadi, Vice President and CISO, Teva Pharmaceuticals
Ilan Abadi is the VP and CISO at Teva Pharmaceutical, a $19B multinational pharmaceutical company. He has 19 years of experience in security at global firms where his responsibilities included management of cyber incident response in heavily regulated OT environments. Ilan’s previous positions include being the CISO for the cybercrime unit of the National Israeli Police and CISO for a leading satellite broadcasting firm.

About Daniel Shugrue, Director of Industrial Cybersecurity, CyberX
Daniel Shugrue has 20 years of experience working in software and security technology. Prior to working at CyberX, he directed Security Product Marketing at Akamai Technologies and worked in Product Marketing at RSA, the security division of EMC. 

About CyberX
CyberX delivers the only industrial cybersecurity platform built by blue-team experts with a track record of defending critical national infrastructure. That difference is the foundation for the most widely deployed platform for continuously reducing IIoT and ICS risk and preventing costly production outages, safety failures, environmental incidents, and theft of sensitive intellectual property.

Notable CyberX customers include 2 of the top 5 US energy providers; a top 5 global pharmaceutical company; a top 5 US chemical company; and national electric and gas utilities across Europe and Asia-Pacific. Strategic partners include industry leaders such as Palo Alto Networks, IBM Security, Splunk, Optiv Security, McAfee, DXC Technology, and Deutsche-Telekom/T-Systems. For more information visit or follow @CyberX_Labs.

Media Contact
Deb Montner
Montner Tech PR